Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

Duopharma scores a first with halal-certified cancer treatment

A blockchain advantage
Share on FacebookShare on Twitter
Bukhari Akhir (left) from JAKIM and Wan Amir- Jeffery Wan Abdul Majid from Duopharma Biotech.

Duopharma Biotech Berhad recorded a new milestone when it became the first pharmaceutical company to receive halal certification for an oncology product, awarded by the Department of Islamic Development Malaysia (JAKIM).

The product is currently approved as an adjuvant treatment for postmenopausal women with early breast cancer as well as a first-line treatment for postmenopausal women with advanced breast cancer.

Produced at Duopharma Biotech’s Highly Potent Active Pharmaceutical Ingredients (HAPI) facility located in Glenmarie, Shah Alam, the halal oncology product is supplied to both Government and private healthcare hospitals in Malaysia and has recently been approved for export to Brunei and Singapore.

Leonard Ariff Abdul Shatar, Group Managing Director, Duopharma Biotech

Duopharma Biotech Group Managing Director, Leonard Ariff Abdul Shatar, said: “This milestone halal certification for an oncology product manufactured at Duopharma Biotech’s HAPI facility is in line with our environmental, social & governance (ESG) commitment, where one of our Key Focus Areas is Access to Medicine.

“We are making continuous efforts to provide consumers and patients with access to much-needed medicines and therapies – assured safe for use and effective, high in quality, hygienic and halal from the start.

“Our state-of-the-art HAPI facility plays a vital role in the fight against many diseases, enabling us to embrace innovation and technology to serve patient needs and expand access to specialised therapies.”

Duopharma Biotech’s cutting-edge HAPI facility is the first cancer medicine manufacturing facility in Malaysia, kickstarting the company’s foray into the oncology segment in 2019. Currently, the facility produces generic treatments for breast cancer, lung cancer, colorectal cancer, cervical cancer and blood cancer.

It is also fully equipped to produce medicines to treat hormone imbalance, as well as cardiovascular, central nervous system and musculoskeletal conditions. The facility has also received Good Manufacturing Practice (GMP) certification from the Malaysian National Pharmaceutical Regulatory Agency (NPRA).

Leonard Ariff said Duopharma Biotech had been working to elevate the position of Halal pharmaceuticals within the global pharmaceutical landscape, in collaboration with stakeholders across the world.

“We aspire to produce a holistic range of safe, effective, quality Halal-certified products to enhance inclusivity in healthcare, enabling all patients to have choices in the therapies and medications they need for their well-being.

“As the halal pharmaceutical leader in Malaysia, we embrace the halalan toyyiban concept, adding another layer of assurance beyond compliance with GMP standards,” Leonard Ariff commented.

Since 1999, Duopharma Biotech has pioneered a range of halal-certified health supplements, including CHAMPS, Flavettes, Proviton and Naturalle products, in compliance with MS 1500:2009 standards. – The Health

Tags: Duopharma BiotechHalal certificationhalal pharmaceuticalLocal NewsOncology productThe Health 2023The Health Jan/Feb 2023theHealth
Previous Post

FWD Takaful launches FWD Medical Care+

Next Post

Covid-19 prevention for high-risk individuals

Live Edition Paper

NOV 2020 ePaper

OCT 2020 ePaper


 

Subscribe for free complimentary live editions:

Recent News

  • MARii and IMR use 4.0 technology
    February 7, 2022
    Through its upgraded laboratory, located in IMR’s laboratories in Setia Alam, […]
  • Yayasan Sultan Ibrahim Johor donates medical equipment worth over RM28 mil
    April 28, 2022
    In an ongoing effort to combat the spread of Covid-19, Yayasan Sultan Ibrahim […]
  • Supporting those with advanced and metastatic cancer
    December 22, 2022
    The Breast Cancer Welfare Association Malaysia (BCWA), Lung Cancer Network […]
  • Navigating the Omicron wave
    April 28, 2022
    Public healthcare capacity and readiness, minimisation of transmission, proper […]
  • Komarkcorp expands face mask business
    September 30, 2021
    PACKAGING solution provider and automatic labeling machine manufacturer […]

Connect

Office

Revon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 3359 1166
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist